Diagnosis and treatment in patients with B-cell lymphoma unclassified that is intermediate between diffuse large B-cell lymphoma and Burkitt’s lymphoma
- Authors: Baryakh EA1, Misyurina AE1, Kovrigina AM1, Obukhova TN1, Gemdzhyan EG1, Vorobyev VI1, Mangasarova Y.K1, Polyakov Y.Y.1, Magomedova AU1, Klyasova GA1, Misyurin VA1, Yatsyk GA1, Shevelev AA1, Kostina IE1, Vorobyev AI1, Kravchenko SK1
-
Affiliations:
- «Гематологический научный центр» Минздрава России
- Issue: Vol 87, No 8 (2015)
- Pages: 77-85
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31817
- ID: 31817
Cite item
Full Text
Abstract
About the authors
E A Baryakh
«Гематологический научный центр» Минздрава РоссииМосква, Россия
A E Misyurina
«Гематологический научный центр» Минздрава РоссииМосква, Россия
A M Kovrigina
«Гематологический научный центр» Минздрава РоссииМосква, Россия
T N Obukhova
«Гематологический научный центр» Минздрава РоссииМосква, Россия
E G Gemdzhyan
«Гематологический научный центр» Минздрава РоссииМосква, Россия
V I Vorobyev
«Гематологический научный центр» Минздрава РоссииМосква, Россия
Ya K Mangasarova
«Гематологический научный центр» Минздрава РоссииМосква, Россия
Yu Yu Polyakov
«Гематологический научный центр» Минздрава РоссииМосква, Россия
A U Magomedova
«Гематологический научный центр» Минздрава РоссииМосква, Россия
G A Klyasova
«Гематологический научный центр» Минздрава РоссииМосква, Россия
V A Misyurin
«Гематологический научный центр» Минздрава РоссииМосква, Россия
G A Yatsyk
«Гематологический научный центр» Минздрава РоссииМосква, Россия
A A Shevelev
«Гематологический научный центр» Минздрава РоссииМосква, Россия
I E Kostina
«Гематологический научный центр» Минздрава РоссииМосква, Россия
A I Vorobyev
«Гематологический научный центр» Минздрава РоссииМосква, Россия
S K Kravchenko
«Гематологический научный центр» Минздрава РоссииМосква, Россия
References
- Kluin PM, Harris NL, Stein H, Leoncini L, Raphael M, Campo E, Jaffe ES. B-cell lymphoma, unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in Who Classification of tumors of haematopoietic and lymphoid tissues, edited by SH Swerdlow, E Campo, NL Harris, ES Jaffe, SA Pileri, H Stein, J Thiele, JW Vardiman. 2008:265-266.
- Jaffe ES, Pittaluga S. Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification. Hematology. Am Soc Hematol Educ Program. 2011;2011:506-514.
- Hasserjian RP, Ott G, Elenitoba-Johnson KS, Balague-Ponz O, de Jong D, de Leval L. Commentary on the WHO classification of tumors of lymphoid tissues (2008): «Gray zone» lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma. J Hematopathol. 2009;2:89-95.
- Барях Е.А., Кравченко С.К., Обухова Т.Н., Звонков Е.Е., Кременецкая А.М., Клясова Г.А., Терехова А.Ю., Воробьев А.И. Лимфома Беркитта: клиника, диагностика, лечение. Клиническая онкогематология. Фундаментальные исследования и клиническаяпрактика. 2009;2(2):137-146.
- Барях Е.А., Кравченко С.К., Кременецкая А.М., Звонков Е.Е., Магомедова А.У., Обухова Т.Н., Попова Ю.Ю., Финк О.С., Клясова Г.А., Шулутко Е.М., Галстян Г.М., Капланская И.Б., Воробьев И.А., Воробьев А.И. Лейкоз/лимфома Беркитта: клинические особенности, диагностические критерии, терапевтическая тактика. Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2010;3(2):138-143.
- Kravchenko SK, Baryakh EA, Zamyatina VI, Perestoronina TN, Fink OS, Gubkin AV, Egorova EK, Zvonkov EE, Ilyushkina EA, Krasilnikova BB, Morozova AK, Vorobyev IA, Kaplanskaya IB, Klyasova GA, Obukhova TN, Kremenetskaya AM, Vorobyev AI. High-dose therapy of burkitt’s lymphoma in patients over 40 years of age. Терапевтический архив. 2008;7:9-18.
- Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275-282.
- Kanungo A, Medeiros LJ, Abruzzo LV, Lin P. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis. Modern Pathology. 2006;19:25-33.
- Le Gouill S, Talmant P, Touzeau C, Moreau A, Garand R, Juge-Morineau N, Gaillard F, Gastinne T, Milpied N, Moreau P, Harousseau JL, Avet-Loiseau H. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica. 2007;92:1335-1342.
- Tomita N, Tokunaka M, Nakamura N, Takeuchi K, Koike J, Motomura S, Miyamoto K, Kikuchi A, Hyo R, Yakushijin Y, Masaki Y, Fujii S, Hayashi T, Ishigatsubo Y, Miura I. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica. 2009;94(7):935-943.
- Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, Dyer MJ, Siebert R, Kuruvilla J, Klasa R, Connors JM, Gascoyne RD, Horsman DE. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009;114:2273-2279.
- Niitsu N, Okamoto M, Miura I, Hirano M. Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations. Leukemia. 2009;23:777-783.
- Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol. 2010;34(3):327-340.
- Greenwood M, Armytage T, Fay K. Outcomes of allogeneic stem cell transplantation for non-Hodgkin lymphoma with concurrent MYC and BCL2 translocations: a single center retrospective analysis. Hematol Oncol. 2013;3(Suppl. 1):103.
- Oki Y, Noorani M, Davis RE, Davis RE, Neelapu SS, Ma L, Ahmed M, Rodriguez MA, Hagemeister FB, Fowler N, Wang M, Fanale MA, Nastoupil L, Samaniego F, Lee HJ, Dabaja BS, Pinnix CC, Medeiros LJ, Nieto Y, Khouri I, Kwak LW, Turturro F, Romaguera JE, Fayad LE, Westin JR. Double hit lymphoma: M.D. Anderson Experince. Blood. 2013;122(21):1776.
- Sun H, Savage K, Karsan A. Outcome of patients wits double-hit lymphomas treated with CODOX-M/IVAC + R followed by hematopoietic stem cell transplantation in British Columbia. Blood. 2013;122(21):1788.
- Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ, Lee LX, Barta SK, Melinamani S, Karmali R, Adeimy C, Smith S, Dalal N, Nabhan C, Peace D, Vose J, Evens AM, Shah N, Fenske TS, Zelenetz AD, Landsburg DJ, Howlett C, Mato A, Jaglal M, Chavez JC, Tsai JP, Reddy N, Li S, Handler C, Flowers CR, Cohen JB, Blum KA, Song K, Sun HL, Press O, Cassaday R, Jaso J, Medeiros LJ, Sohani AR, Abramson JS. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood. 2014;124(15): 2354-2361.
- Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM. Double-hit B-cell lymphomas. Blood. 2011;117(8):2319-2931.
- Hoeller S, Copie-Bergman C. Grey Zone Lymphomas: Lymphomas with Intermediate Features. Advances in Hematology. 2012, article ID 460801.
- Tauro S, Cochrane L, Lauritzsen GF, Baker L, Delabie J, Roberts C, Mahendra P, Holte H. Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): A comparison of two adapted BFM protocols. Am J Hematol. 2010;85(4):261-263.
- Kobayashi T, Tsutsumi Y, Sakamoto N, Nagoshi H, Yamamoto-Sugitani M, Shimura Y, Mizutani S, Matsumoto Y, Nishida K, Horiike S, Asano N, Nakamura S, Kuroda J, Taniwaki M. Double-hit Lymphomas Constitute a Highly Aggressive Subgroup in Diffuse Large B-cell Lymphomas in the Era of Rituximab. Jpn J Clin Oncol. 2012;42(11):1035-1042.
- Aukema SM, Kreuz M, Kohler CW, Rosolowski M, Hasenclever D, Hummel M, Küppers R, Lenze D, Ott G, Pott C, Richter J, Rosenwald A, Szczepanowski M, Schwaenen C, Stein H, Trautmann H, Wessendorf S, Trümper L, Loeffler M, Spang R, Kluin PM, Klapper W, Siebert R. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma. Haematologica. 2014;99(4):726-735.
- Valera A, López-Guillermo A, Cardesa-Salzmann T, Climent F, González-Barca E, Mercadal S, Espinosa I, Novelli S, Briones J, Mate JL, Salamero O, Sancho JM, Arenillas L, Serrano S, Erill N, Martínez D, Castillo P, Rovira J, Martínez A, Campo E, Colomo L, Grup per l’Estudi dels Limfomes de Catalunya i Balears (GELCAB). MYC Protein Expression And Genetic Alterations Have Prognostic Impact In Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy. Haematologica. 2013;98(10):1554-1562.
- Yamazaki T, Ohno H. Double-hit lymphoma with t(8;14)(q24;q32) and t(12;14)(q24;q32) chromosomal translocations. Intern Med. 2011;50(21):2659-2662.
![](/img/style/loading.gif)